Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV.
Maria Vittoria CossuAntonio D'AvolioCristina GervasoniAndrea GiacomelliDario CattaneoDavide MoschesePublished in: Antimicrobial agents and chemotherapy (2024)